4 results

• Dupixent CTCL Studies Highlighted Cancer Risks For Years, Lawsuit Alleges

  August 11, 2026

  Irvin Jackson

  A Dupixent CTCL lawsuit indicates manufacturers have long known the eczema treatment was linked to an increased cancer risk, but failed to warn doctors or patients.

• CTCL Lawsuit Alleges Diagnosis Came After Less Than a Year of Dupixent Use

  July 29, 2026

  Irvin Jackson

  A Dupixent CTCL lawsuit claims that the manufacturer intentionally failed to warn patients or the medical community about the eczema treatment's potential cancer risks.

• Genzyme Drug Contamination: Foreign Particles may be in Cerezyme, Fabrazyme, Myozyme, Aldurazyme and Thyrogen

  November 17, 2009

  AboutLawsuits

  The FDA has warned healthcare professionals that several important drugs manufactured by Genzyme Corp., which are used to treat rare...

• Thymoglobulin Recall: Anti-Rejection Drug May Not Be Stable

  September 10, 2008

  AboutLawsuits

  The U.S. Food and Drug Administration (FDA) posted information Tuesday about a Thymoglobulin recall for one lot of the anti-rejection...